Skip to main content
. 2014 Nov 18;14:833. doi: 10.1186/1471-2407-14-833

Table 2.

Summary of the DVH analysis for the CTV, PTV and OARs for the entire cohort of patients

Parameter CRT RA
CTV PTV CTV PTV
Mean (Gy) 49.3 ± 1.3 48.8 ± 1.0 50.9 ± 0.7 50.2 ± 0.5
D 1% (Gy) 60.8 ± 1.2 60.4 ± 1.1 59.7 ± 0.6 54.4 ± 1.4
D 99% (Gy) 44.4 ± 0.6 43.4 ± 1.0 48.4 ± 0.6 46.9 ± 0.8
CTV_Boost PTV_Boost CTV_Boost PTV_Boost
Mean (Gy) 60.4 ± 1.1 60.2 ± 1.0 59.5 ± 0.3 59.3 ± 0.3
D 1% (Gy) 61.3 ± 1.3 61.5 ± 1.3 60.6 ± 0.4 61.0 ± 0.4
D 99% (Gy) 58.9 ± 0.8 57.9 ± 1.4 57.8 ± 1.6 55.5 ± 4.8
Bladder
Mean (Gy) 47.2 ± 5.6 (p = 0.02) 34.2 ± 6.6
V 40 Gy (%) 86.4 ± 25.4 (p < 0.001) 33.8 ± 18.2
Bowel
Mean (Gy) 30.8 ± 9.1 26.5 ± 6.8
V 40 Gy (%) 41.4 ± 27.7 (p = 0.04) 22.9 ± 9.0
Femoral heads
D 1% (Gy) 51.4 ± 7.2 43.8 ± 2.6
Genitals
V 40 Gy (%) 42.6 ± 24.8 (p < 0.01) 22.1 ± 10.3
Healthy tissue
Mean (Gy) 18.9 ± 4.4 (p = 0.01) 11.9 ± 1.6
V 10 Gy (%) 53.6 ± 11.9 (p = 0.03) 41.4 ± 6.1

Data are reported as average values plus or minus standard deviation.

Dx%: dose received by at least x% of the volume; Vx%: volume receiving at least x% of the dose. p values from independent samples test have been reported only for cases with p < 0.05.